This page collects vetted references on medical safety, regulatory guidance, and clinical background for anyone researching this topic.
Long term outcome of Tardive Dyskinesia after Reglan Resource Guide
In-depth context and analysis on this topic for researchers and advocates.
Reference: European Medicines Agency (EMA)
Authoritative source for clinical, regulatory, and public-health background reading.
Reference: U.S. Food and Drug Administration (FDA)
Authoritative source for clinical, regulatory, and public-health background reading.